A detailed history of Capital Analysts, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Capital Analysts, LLC holds 1,725 shares of WST stock, worth $517,172. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,725
Previous 1,725 -0.0%
Holding current value
$517,172
Previous $683,000 16.84%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$318.29 - $392.21 $15,914 - $19,610
-50 Reduced 2.82%
1,725 $607,000
Q3 2023

Nov 13, 2023

SELL
$354.9 - $412.41 $60,332 - $70,109
-170 Reduced 8.74%
1,775 $666,000
Q1 2023

May 05, 2023

BUY
$232.5 - $346.47 $1,162 - $1,732
5 Added 0.26%
1,945 $674,000
Q4 2022

Feb 08, 2023

SELL
$209.34 - $261.61 $9,420 - $11,772
-45 Reduced 2.27%
1,940 $457,000
Q3 2022

Nov 14, 2022

SELL
$246.08 - $343.65 $147,894 - $206,533
-601 Reduced 23.24%
1,985 $488,000
Q2 2022

Aug 12, 2022

BUY
$280.61 - $420.45 $7,015 - $10,511
25 Added 0.98%
2,586 $782,000
Q4 2021

Feb 10, 2022

SELL
$402.25 - $471.34 $11,665 - $13,668
-29 Reduced 1.12%
2,561 $1.2 Million
Q2 2021

Aug 05, 2021

BUY
$284.77 - $363.2 $9,966 - $12,712
35 Added 1.37%
2,590 $929,000
Q1 2021

May 17, 2021

BUY
$257.29 - $307.53 $163,379 - $195,281
635 Added 33.07%
2,555 $720,000
Q4 2020

Feb 16, 2021

BUY
$261.16 - $301.66 $88,794 - $102,564
340 Added 21.52%
1,920 $544,000
Q3 2020

Nov 12, 2020

BUY
$224.99 - $288.02 $37,123 - $47,523
165 Added 11.66%
1,580 $434,000
Q2 2020

Aug 07, 2020

SELL
$149.8 - $227.17 $11,984 - $18,173
-80 Reduced 5.35%
1,415 $321,000
Q1 2020

May 08, 2020

BUY
$128.96 - $174.76 $192,795 - $261,266
1,495 New
1,495 $228,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $22.2B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.